Tweedy Browne's VRTX Position Overview
Tweedy Browne (via Tweedy, Browne Co LLC) currently holds 39,065 shares of Vertex Pharmaceuticals Incorporated (VRTX) worth $15.3 M, representing 1.33% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Tweedy Browne has maintained a strategic position in VRTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 1,812 shares. Largest reduction occurred in Q4 2024, reducing 12,969 shares.
Analysis based on 13F filings available since 2013 Q2
Tweedy Browne's Vertex Pharmaceuticals Incorporated (VRTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vertex Pharmaceuticals Incorporated (VRTX) Trades by Tweedy Browne
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2023 | +75,004 | New Buy | 75,004 | $347.74 |
| Q4 2023 | -8,240 | Reduce 10.99% | 66,764 | $406.89 |
| Q1 2024 | -65 | Reduce 0.10% | 66,699 | $418.01 |
| Q2 2024 | -12,353 | Reduce 18.52% | 54,346 | $468.72 |
| Q3 2024 | -746 | Reduce 1.37% | 53,600 | $465.08 |
| Q4 2024 | -12,969 | Reduce 24.20% | 40,631 | $402.70 |
| Q1 2025 | -2,315 | Reduce 5.70% | 38,316 | $484.82 |
| Q2 2025 | -1,063 | Reduce 2.77% | 37,253 | $445.20 |
| Q3 2025 | +1,812 | Add 4.86% | 39,065 | $391.64 |
Tweedy Browne's Vertex Pharmaceuticals Incorporated Investment FAQs
Tweedy Browne first purchased Vertex Pharmaceuticals Incorporated (VRTX) in Q3 2023, acquiring 75,004 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne has held Vertex Pharmaceuticals Incorporated (VRTX) for 9 quarters since Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne's largest addition to Vertex Pharmaceuticals Incorporated (VRTX) was in Q3 2023, adding 75,004 shares worth $26.08 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Tweedy Browne's firm, Tweedy, Browne Co LLC, owns 39,065 shares of Vertex Pharmaceuticals Incorporated (VRTX), valued at approximately $15.3 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Vertex Pharmaceuticals Incorporated (VRTX) represents approximately 1.33% of Tweedy Browne's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne's peak holding in Vertex Pharmaceuticals Incorporated (VRTX) was 75,004 shares, as reported at the end of Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.